Navigation Links
Adams Respiratory Therapeutics and Lipocine Enter into License and Collaboration Agreement
Date:9/19/2007

ave been issued and are pending on these proprietary technologies.

Under the terms of the agreement, Adams receives an exclusive, royalty- bearing license from Lipocine to develop and market multiple prescription adult cough products in North America. Lipocine is responsible for completing the product development work and will be eligible to receive reimbursements and payments in exchange for completing certain pre-defined development milestones. Adams will be responsible for performing all aspects of clinical development, regulatory submission, manufacture and commercial operations. Financial terms of the deal are not being disclosed. Adams reconfirms that it expects diluted earnings per share in fiscal 2008 to be in the range of $1.55 to $1.75, as previously disclosed in an August 21, 2007 press release.

About Adams Respiratory Therapeutics, Inc.

Adams is a specialty pharmaceutical company focused on the late-stage development, commercialization and marketing of over-the-counter and prescription pharmaceuticals for the treatment of respiratory disorders.

About Lipocine Inc.

Lipocine Inc. is a pharmaceutical company leveraging its proprietary drug delivery technologies to commercialize innovative pharmaceutical products. Lipocine business objectives are to develop products with established drugs that have patient friendly attributes such as faster absorption, lower dose, fewer side effects, less frequent dosing, and no food effect.

Adams Respiratory Therapeutics Forward-Looking Statement

This press release contains certain "forward-looking" statements, including Adams' application of the Lip'ral(TM) technology to prescription cough products, Adams' competitiveness in the prescription cough and cold market and Adams' future financial performance. Such forward-looking statements can be identified by the words "could," "will" and similar expressions and are subject to risks and uncertainties that could cause actual results to
'/>"/>

SOURCE Adams Respiratory Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO
2. NanoRite Innovation Center opens with small science, big promise
3. UW-Madison to receive $125M for bioenergy research center
4. WARF enters licensing agreements for stem cell products
5. Internet-enabled niche markets take center stage
6. Virent enters agreement with Shell Oil unit to make hydrogen with biomass
7. TomoTherapy opens technical training center
8. Stem cell and regenerative medicine center to aid education and commerce
9. Mega-Metro Center may go beyond Chicago and Wisconsin
10. Software company enters health space with RFID solutions on hold
11. Former Fiserv exec to enter Business Hall of Fame
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... The report "Offshore Support Vessel Market ... Supply Vessels, Multi-Purpose Service Vessel, Crew Boats, Standby & ... Trends & Forecast to 2018", defines and segments the ... the global revenue. , Offshore support vessel market is ... to $ 91,228.8 Million by 2018, with a CAGR ...
(Date:10/31/2014)... IL (PRWEB) October 30, 2014 ... Insight Product Developmentā€™s decades-long heritage in successful medical ... world context for what it takes to successfully ... space. As part of a two-hour on-site class, ... Kellogg school of business, McCormick School of Engineering, ...
(Date:10/31/2014)... 31, 2014 This is a ... China Biocides industry. The report provides basic biocides ... chain structure as well as industry overview. This ... domestic market as well as Global industry analysis ... report on the Chinese biocides industry ...
(Date:10/31/2014)... (PRWEB) October 31, 2014 Stronger ... healthcare, construction, finance and consumer electronics will help ... reason, industry research firm IBISWorld has added a ... its growing industry report collection. , The Biometrics ... for biometric technologies such as fingerprint, iris, retina ...
Breaking Biology Technology:Offshore Support Vessel Market Projected to Reach $91,228.8 Million by 2018 - Report by MarketsandMarkets 2Offshore Support Vessel Market Projected to Reach $91,228.8 Million by 2018 - Report by MarketsandMarkets 3Offshore Support Vessel Market Projected to Reach $91,228.8 Million by 2018 - Report by MarketsandMarkets 4Insight Product Development Gives Northwestern University Students Foundation for Innovation Success 2Insight Product Development Gives Northwestern University Students Foundation for Innovation Success 3Biocides Market for International & Chinese Regional Development Analysis Now Available at DeepResearchReports.com 2Biocides Market for International & Chinese Regional Development Analysis Now Available at DeepResearchReports.com 3Biometrics Scan Software in the US Industry Market Research Report Now Available from IBISWorld 2Biometrics Scan Software in the US Industry Market Research Report Now Available from IBISWorld 3
... have identified a molecule that can form the basis for ... first step toward a medicine that could actually stop the ... loss of memory during the first phases of the disease. ... of this research. A first step, however, is still a ...
... in European UnionSAN MATEO, Calif., March 19 NeurogesX, ... focused on developing and commercializing novel pain management therapies, ... Friday, March 20, 2009 at 9:00 a.m. ET (6:00 ... results and the European Medicines Agency,s (EMEA) Committee for ...
... MedNet Solutions, a global life sciences technology ... today announced that one of the world,s largest ... (IIT) Management System. This system provides a ... entire IIT lifecycle... from proposal to publication... helping ...
Cached Biology Technology:Progress toward an Alzheimer's drug that saves brain cells 2NeurogesX to Hold Conference Call to Discuss Fourth Quarter and Year-End 2008 Financial Results and European Regulatory Update 2NeurogesX to Hold Conference Call to Discuss Fourth Quarter and Year-End 2008 Financial Results and European Regulatory Update 3NeurogesX to Hold Conference Call to Discuss Fourth Quarter and Year-End 2008 Financial Results and European Regulatory Update 4Top Ten Pharma Company Deploys MedNet Solutions' Investigator Initiated Trial Management System 2
(Date:10/29/2014)... Online registration is open for the ... Scientific Meeting. SIR 2015 is the one ... trainees and related health care professionals can ... image-guided science and technologies being presented, discussed ... community in minimally invasive, image-guided medicine, SIR ...
(Date:10/29/2014)... sunlight to make their food, but they also need protection ... discovered a group of molecules in plants that shields them ... Journal of the American Chemical Society , one team reports ... , Timothy Zwier and colleagues at Purdue University note that ... cause serious damage to plant DNA and, as a result, ...
(Date:10/29/2014)... the rage. Thousands of scientists worldwide are conducting research ... dioxide nanoparticles from sun creams can get through the ... electronic products are as hazardous for the lungs as ... can get into the blood via the intestinal flora, ... flowing – and the number of scientific projects is ...
Breaking Biology News(10 mins):SIR 2015: Interventional radiology shapes tomorrow's medicine 2Nanosafety research: The quest for the gold standard 2Nanosafety research: The quest for the gold standard 3
... able to target and destroy triple negative breast cancer, ... access journal Breast Cancer Research . Researchers from ... was able to destroy breast cancer cells and reduce ... cancers are found at diagnosis to be triple negative. ...
... -- With chronic diseases continuing to rise, health ... find "cures" continuing to take in billions each year ... small but growing sector is finding answers from an ... practices that rely such unlikely factors as numbers, sacred ...
... University physicists and University of Miami biologists addresses ... How do living cells figure out when and ... Professor Dimitrios Vavylonis and Associate Professor Fulvia Verde ... precipitating a ballet of proteins that change its ...
Cached Biology News:Blocking DNA: HDAC inhibitor targets triple negative breast cancer 2Healing Method from Australia Addresses the Human Genome 2A cell's first steps: Building a model to explain how cells grow 2
...
ELISpot kit for human Granzyme B. Kits contain PVDF plates, capture & detection antibodies, streptavidin-ALP, BSA, Skimmed dry milk, BCIP/NTB substrate, and wash buffer...
Request Info...
Applications: (+) Immunocytochemistry and immunohistochemistry...
Biology Products: